Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients
Stopped Low recruitment
Conditions
- 2019 Novel Coronavirus Disease
- 2019 Novel Coronavirus Infection
- 2019-nCoV Disease
- 2019-nCoV Infection
- COVID-19
- COVID-19 Pandemic
- COVID-19 Virus Disease
- COVID-19 Virus Infection
- Covid19
- Coronavirus Disease 2019
- SARS-CoV2 Infection
- SARS-CoV-2 Acute Respiratory Disease
Interventions
- DRUG: Famotidine
- DRUG: Celecoxib
- DRUG: Placebo
Sponsor
Leidos Life Sciences
Collaborators